๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Breast Cancer Risk

Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer NCT04913064NA1 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Questionnaire Administration, White Button Mushroom Extract Night-shift Work and Breast Cancer NCT06786949n/a2 sites๐Ÿ“ Bologna๐Ÿ“ Messina IRCCS Azienda Ospedaliero-Universitaria di Bologna ยท Tests: Questionnaire, Blood samples for biomarker measurement Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSenseยฎ Cryoablation (ChoICE Trial) NCT07629206NA3 sites๐Ÿ“ Glendale๐Ÿ“ Portland๐Ÿ“ Germantown IceCure Medical Ltd. ยท Tests: Cryoablation PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC NCT06533384Phase 31 site๐Ÿ“ Guangzhou Guangdong Provincial People's Hospital ยท Tests: As per the germline BRCA1/2 mutation status, the selection of either Fuzuloparib or capecitabine in combination with Caโ€ฆ Factors Associated With Breast Cancer Risks and Outcomes NCT07294703n/a7 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Survey Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients NCT05350722NA7 sites๐Ÿ“ Sydney๐Ÿ“ Almere Stad๐Ÿ“ Amstelveen Amsterdam UMC, location VUmc ยท Tests: Single dose ablative radiotherapy Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks NCT05212454Phase 31 site๐Ÿ“ Hanzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: Capecitabine MELIORA Data Collection Campaigns NCT07190066NA7 sites๐Ÿ“ Athens๐Ÿ“ Kaunas๐Ÿ“ Kaunas Harokopio University ยท Tests: Data Collection campaign The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer NCT06698679n/a1 site๐Ÿ“ Shenyang Shengjing Hospital ยท Tests: No intervention Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon NCT07264790Phase 11 site๐Ÿ“ Durham Duke University ยท Tests: Minoxidil, Hair mousse Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence. NCT07443774n/a1 site๐Ÿ“ Grenoble University Hospital, Grenoble Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer NCT06781762n/a1 site๐Ÿ“ Toronto University of Toronto ยท Tests: N/A (Usual Care) Single Pre-Operative Radiation Therapy - With Delayed or No Surgery (SPORT-DNS) NCT05217966NA2 sites๐Ÿ“ Montreal๐Ÿ“ Montreal Maisonneuve-Rosemont Hospital ยท Tests: Radiation: Single Pre-Operative Radiation Therapy Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients NCT06722599n/a1 site๐Ÿ“ Beijing Shu Wang The PREDICT Registry: NCT03448926n/a30 sites๐Ÿ“ Scottsdale๐Ÿ“ La Jolla๐Ÿ“ San Mateo PreludeDx ยท Tests: Treatment recommendation surveys, 7-gene biosignature Evaluating Harms and Benefits of Endocrine Therapy in Patients โ‰ฅ70 Years of Age With Lower Risk Breast Cancer NCT04921137Phase 48 sites๐Ÿ“ Edmonton๐Ÿ“ Kitchener๐Ÿ“ London Ottawa Hospital Research Institute ยท Tests: No endocrine therapy, Endocrine therapy Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib NCT07237256Phase 3138 sites๐Ÿ“ Amiens๐Ÿ“ Angers๐Ÿ“ Argenteuil UNICANCER ยท Tests: Chemotherapy followed by endocrine therapy and ribociclib treatment, De-escalation Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy NCT05472792Phase 21 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: Accelerated Partial Breast Irradiation (APBI), tamoxifen, anastrozole, exemestane, letrozole, fulvestrant, toremifene CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS) NCT07019363Phase 31 site๐Ÿ“ Shanghai Fudan University ยท Tests: Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane), Standard endocrine therapy combined with CDK4/6 Inhibโ€ฆ Increasing Germline Genetic Testing for Patients With Cancer NCT07307664NA10 sites๐Ÿ“ Los Angeles๐Ÿ“ Orlando๐Ÿ“ Decatur Josh Peterson ยท Tests: Implementation strategies Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breast Cancer NCT07531693n/a1 site๐Ÿ“ Erlangen Institut fuer Frauengesundheit Women Informed to Screen Depending on Measures of Risk (Wisdom Study) NCT02620852NA11 sites๐Ÿ“ Birmingham๐Ÿ“ Irvine๐Ÿ“ Los Angeles University of California, San Francisco ยท Tests: Complete a health questionnaire, Provide a saliva sample for genetic testing, Screening advice based on a comprehensiveโ€ฆ Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy: Impact of Informing Them of AI-predicted Risk NCT07187726NA27 sites๐Ÿ“ Arras๐Ÿ“ Beuvry๐Ÿ“ Bordeaux UNICANCER ยท Tests: XAINET AI tool MEASUREMENT OF CIRCULATING MUTATION BURDEN NCT06792721n/a1 site๐Ÿ“ Caen Centre Francois Baclesse ยท Tests: Mutation Burden cfMB analysis Seroma of the Mammary Gland NCT05899387NA1 site๐Ÿ“ Augsburg University Hospital Augsburg ยท Tests: Swap collection, Seroma punction, Blood sampling, Sonographic correlation Seroma CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer๏ผˆCinnamon๏ผ‰ NCT07432178Phase 31 site๐Ÿ“ Shanghai Fudan University ยท Tests: Dalpiciclib+AI ยฑ OFS, TC (Docetaxel + Cyclophosphamide) ร— 4 cycles- endocrine therapy Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI) NCT07067437NA23 sites๐Ÿ“ Lyon๐Ÿ“ Nancy๐Ÿ“ Nice National Institute of Oncology, Hungary ยท Tests: single-fraction very accelerated partial breast irradiation Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer NCT06607757Phase 225 sites๐Ÿ“ Augsburg๐Ÿ“ Berlin๐Ÿ“ Bielefeld GBG Forschungs GmbH ยท Tests: Capivasertib, Fulvestrant injection Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) NCT06797635Phase 217 sites๐Ÿ“ Santa Monica๐Ÿ“ Skokie๐Ÿ“ Billings Merck Sharp & Dohme LLC ยท Tests: Patritumab deruxtecan, Pembrolizumab, Paclitaxel, Carboplatin, Doxorubicin hydrochloride BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer NCT04891068Phase 21 site๐Ÿ“ Chicago University of Illinois at Chicago ยท Tests: Azacitidine
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy